Stability of gabapentin in extemporaneously compounded oral suspensions.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 28414771.
- Also identified by DOI 10.1371/journal.pone.0175208 and PMC identifier 5393583.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study reports the stability of extemporaneously prepared gabapentin oral suspensions prepared at 100 mg/mL from bulk drug and capsules in either Oral Mix or Oral Mix SF suspending vehicles. Suspensions were packaged in amber plastic bottles and amber plastic syringes at 25°C / 60%RH for up to 90 days. Throughout the study period, the following tests were performed to evaluate the stability of the preparations: organoleptic inspection to detect homogeneity, color or odor changes; pH measurements; and gabapentin assay using a stability-indicating HPLC-UV method. As crystallization was observed at 5°C, storage at this temperature condition is not recommended. All preparations stored at 25°C / 60%RH remained stable for the whole study duration of 90 days.
Medical subject headings
- Amines
- Anticonvulsants
- Cyclohexanecarboxylic Acids
- gamma-Aminobutyric Acid